(Q30723921)

26 June 2017

1 reference

title

Primary prophylaxis of variceal hemorrhage (English)

1 reference

26 June 2017

0 references

Lowe RC

1

1 reference

26 June 2017

Grace ND

series ordinal

2

1 reference

26 June 2017

publication date

1 August 2001

1 reference

26 June 2017

published in

Clinics in liver disease

1 reference

26 June 2017

volume

5

1 reference

26 June 2017

issue

3

1 reference

26 June 2017

page(s)

665-676

1 reference

Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Primary prevention of bleeding from esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Pharmacological treatment of portal hypertension: an evidence-based approach

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Portal pressure, presence of gastroesophageal varices and variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Pharmacologic therapy of portal hypertension and variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Esophageal varices. I. Clinical presentation, medical therapy, and endoscopic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970187-2

7 January 2021

10.1016/S1089-3261(05)70187-2

Identifiers

DOI

1 reference

26 June 2017

1 reference